How often is Leqvio administered?

Leqvio, also known as inclisiran, is administered every 6 months. This biannual dosing schedule is designed to maximize convenience for patients while ensuring sustained effectiveness in lowering LDL cholesterol levels. The mechanism behind Leqvio relies on RNA interference, which provides a long-lasting impact on the liver’s ability to produce cholesterol, thus requiring only two doses per year.

This dosing regimen is particularly beneficial for maintaining patient adherence compared to medications that require more frequent administration. Regular follow-ups with the healthcare provider are still essential, but the extended interval for administration allows patients to have less frequent appointments for their cholesterol management. The other options suggest more frequent or less frequent dosing, which is not aligned with the established protocol for Leqvio.